AAAAAA
Results:
1-10
|
Results: 10
Authors:
TAGGART H
KELLY R
Citation: H. Taggart et R. Kelly, TOLERABILITY OF ALENDRONATE - REPLY, BMJ. British medical journal, 316(7141), 1998, pp. 1390-1390
Authors:
KELLY R
TAGGART H
Citation: R. Kelly et H. Taggart, HYPOPARATHYROIDISM - PRESENTING 40 YEARS AFTER THYROID-SURGERY, Ulster medical journal, 67(1), 1998, pp. 63-64
Authors:
KELLY R
TAGGART H
Citation: R. Kelly et H. Taggart, INCIDENCE OF GASTROINTESTINAL SIDE-EFFECTS DUE TO ALENDRONATE IS HIGHIN CLINICAL-PRACTICE, BMJ. British medical journal, 315(7117), 1997, pp. 1235-1235
Authors:
ONEILL B
TAGGART H
Citation: B. Oneill et H. Taggart, SEVERE REFRACTORY CONGESTIVE CARDIAC-FAILURE IN AN ELDERLY MAN, Postgraduate medical journal, 73(859), 1997, pp. 315-316
Authors:
HEANEY A
STEELE I
TAGGART H
Citation: A. Heaney et al., LONG-TERM EFFICACY OF CYCLICAL ETIDRONATE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS, Irish journal of medical science, 166(4), 1997, pp. 257-259
Authors:
TAGGART H
Citation: H. Taggart, AUDIT IN OSTEOPOROSIS, Osteoporosis international, 6, 1996, pp. 28-29
Authors:
TAGGART H
Citation: H. Taggart, USE OF NASAL CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITHLOW BONE-DENSITY, Journal of bone and mineral research, 11, 1996, pp. 625-625
Authors:
HEANEY A
STEELE I
TAGGART H
Citation: A. Heaney et al., RESPONSE RATES OF BONE-MINERAL DENSITY AT SPINE AND HIP IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH CYCLICAL ETIDRONATE, Journal of bone and mineral research, 11, 1996, pp. 650-650
Authors:
MCKNIGHT A
STEELE K
MILLS K
GILCHRIST C
TAGGART H
Citation: A. Mcknight et al., BONE-MINERAL DENSITY IN RELATION TO MEDICAL AND LIFE-STYLE RISK-FACTORS FOR OSTEOPOROSIS IN PREMENOPAUSAL, MENOPAUSAL AND POSTMENOPAUSAL WOMEN IN GENERAL-PRACTICE, British journal of general practice, 45(395), 1995, pp. 317-320
Authors:
TAGGART H
CRAWFORD V
Citation: H. Taggart et V. Crawford, REDUCED BONE-DENSITY OF THE HIP IN ELDERLY PATIENTS WITH PARKINSONS-DISEASE, Age and ageing, 24(4), 1995, pp. 326-328
Risultati:
1-10
|